FR1748M - Médicament a base d'un amide d'acide benzoique substitué. - Google Patents

Médicament a base d'un amide d'acide benzoique substitué.

Info

Publication number
FR1748M
FR1748M FR887088A FR887088A FR1748M FR 1748 M FR1748 M FR 1748M FR 887088 A FR887088 A FR 887088A FR 887088 A FR887088 A FR 887088A FR 1748 M FR1748 M FR 1748M
Authority
FR
France
Prior art keywords
benzoic acid
acid amide
product based
medicinal product
substituted benzoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR887088A
Other languages
English (en)
Inventor
Ernst Jucker
Adolf J Lindenmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1254760A external-priority patent/CH396905A/de
Priority claimed from FR878200A external-priority patent/FR1448711A/fr
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of FR1748M publication Critical patent/FR1748M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/32—Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR887088A 1960-11-09 1962-02-06 Médicament a base d'un amide d'acide benzoique substitué. Expired FR1748M (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH1254760A CH396905A (de) 1960-11-09 1960-11-09 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1354460 1960-12-02
CH654761A CH418335A (de) 1960-11-09 1961-06-06 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1518864A CH412892A (de) 1960-11-09 1961-09-11 Verfahren zur Herstellung von neuen Hydrazin-Derivaten
CH1047461 1961-09-11
FR878200A FR1448711A (fr) 1960-11-09 1961-11-07 Nouveaux dérivés de l'hydrazine et leur préparation

Publications (1)

Publication Number Publication Date
FR1748M true FR1748M (fr) 1963-03-25

Family

ID=43798563

Family Applications (1)

Application Number Title Priority Date Filing Date
FR887088A Expired FR1748M (fr) 1960-11-09 1962-02-06 Médicament a base d'un amide d'acide benzoique substitué.

Country Status (7)

Country Link
US (2) US3445573A (fr)
BR (1) BR6134007D0 (fr)
CH (2) CH418335A (fr)
FR (1) FR1748M (fr)
GB (1) GB939468A (fr)
LU (1) LU40792A1 (fr)
NL (1) NL270803A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1586468A (en) * 1976-10-29 1981-03-18 Anphar Sa Piperidine derivatives
EA200500234A1 (ru) 2002-08-19 2005-08-25 Пфайзер Продактс Инк. Комбинированная терапия гиперпролиферативных болезней
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
WO2020150473A2 (fr) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043874A (en) * 1960-05-09 1962-07-10 Parke Davis & Co 4-halo-3-sulfamoylbenzoic acid derivatives and methods for producing same
CH430711A (de) * 1963-12-20 1967-02-28 Sandoz Ag Verfahren zur Herstellung von neuen heterocyclischen Verbindungen

Also Published As

Publication number Publication date
BR6134007D0 (pt) 1973-05-31
LU40792A1 (fr) 1962-05-07
NL270803A (fr)
CH412892A (de) 1966-05-15
US3445573A (en) 1969-05-20
US3459756A (en) 1969-08-05
CH418335A (de) 1966-08-15
GB939468A (en) 1963-10-16

Similar Documents

Publication Publication Date Title
FR1981M (fr) Médicament anti-ulcéreux a base d'esters de l'acide farnésyl-acétique.
FR1038M (fr) Médicament a base d'aspirine.
FR1445M (fr) Un nouveau médicament, la n<2>,n<2>-diméthylhydrazide de l'acide 4-chloro-3-sulfamylbenzoique.
FR2886M (fr) Médicament a base de dérivés de l'acide anthranilique.
FR1382M (fr) Médicament nouveau a base d'acide n-(2,6-dichloro-3-éthylphényl)-anthranilique.
FR100M (fr) Médicament cholérétique a base d'acide 1-cétocyclododécyl-2-acétique.
FR3246M (fr) Médicaments a base d'acide phospho-énol-pyruvique.
FR3026M (fr) Médicament narcotique a base d'ester n-propylique de l'acide 3-méthoxy-4-n-éthyloxy-n-éthylcarbaminométhoxyphénylacétique.
FR178F (fr) Médicament a base de dérivé d'acide phénothiazine carboxylique-3.
FR3189M (fr) Médicament a base d'acide 2-amino-éthanesulfonique.
FR24M (fr) Médicament a base de dérivé d'hyoscyamine.
FR1093M (fr) Médicament a base de dérivé d'acide phénoxy-acétique.
FR3795M (fr) Médicaments a base d'acide quinoléique.
FR1144M (fr) Médicament a base de 1.2-diaryl-3.5-dioxo-pyrazolidines.
FR2138M (fr) Médicament a base d'acide acéthyl salicylique.
FR1813M (fr) Médicament a base d'un dérivé de diphényl-propylamino-propane.
FR1644M (fr) Médicament a base d'acides 2-méthoxy-benzoiques.
FR2038M (fr) Médicament a base de dérivé d'acide acéthyl-salicylique.
FR3571M (fr) Médicaments a base d'acide n-méthyl-amino-butanedioique.
FR3868M (fr) Composition a base d'acide acétyl-salicylique.
FR375M (fr) Médicament a base de sel d'acide chloro-choline-phosphorique.
FR1747M (fr) Médicament a base d'un dérivé du dibenzo-cycloheptane.
FR2877M (fr) Médicament a base d'amides.
FR1360M (fr) Médicament a base d'un dérivé du glutarimide.
FR1470M (fr) Médicament a base d'un dérivé de la colchicine.